The Impact of Thrombocytopenia on Outcome in Patients with Acute Coronary Syndromes: A Single Center Retrospective Study
-
- Andreja Sinkovič
- Department of Medical Intensive Care, University Clinical Center Maribor, Ljubljanska 5, SI-2000 Maribor, Slovenia
-
- Maja Majal
- Department of Hematology, University Clinical Center Maribor, Ljubljanska 5, SI-2000 Maribor, Slovenia
書誌事項
- 公開日
- 2015
- 権利情報
-
- http://creativecommons.org/licenses/by/3.0/
- DOI
-
- 10.1155/2015/907304
- 公開者
- Hindawi Limited
この論文をさがす
説明
<jats:p><jats:italic>Background</jats:italic>. In acute coronary syndromes (ACS), treated by combined antithrombotic therapy and percutaneous coronary interventions (PCI), thrombocytopenia may occur. Our aim was to evaluate predictors and the impact of thrombocytopenia on mortality in high-risk ACS patients.<jats:italic>Methods</jats:italic>. We retrospectively evaluated high-risk ACS patients. Thrombocytopenia was defined as platelet count <140.000/mL or a drop in platelet count of >50% during in-hospital stay. We compared demographic, laboratory, clinical, and mortality data between nonthrombocytopenic and thrombocytopenic ACS patients and evaluated independent predictors of thrombocytopenia.<jats:italic>Results</jats:italic>. In 371 ACS patients, thrombocytopenia was observed in 21.3%. Thrombocytopenic patients were significantly older and, less likely treated by PCIs (72.1% versus 89.7%,<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>p</mml:mi><mml:mo><</mml:mo><mml:mn>0.001</mml:mn></mml:math>) and combined antithrombotic therapy, with increased incidence of in-hospital complications and the use of additional treatments, but with increased mortality at 30 days (27.8% versus 10.2%,<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mi>p</mml:mi><mml:mo><</mml:mo><mml:mn>0.001</mml:mn></mml:math>) and 6 months (35.4% versus 13.6%,<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mi>p</mml:mi><mml:mo><</mml:mo><mml:mn>0.001</mml:mn></mml:math>) when compared to nonthrombocytopenic patients. The use of antibiotics, transfusions, insertion of intra-aortic balloon pump (IABP), and prior stroke independently predicted thrombocytopenia.<jats:italic>Conclusions</jats:italic>. Thrombocytopenia, observed in about 20% of high-risk ACS patients, was associated significantly with in-hospital complications and mortality. Predictors of thrombocytopenia were the use of antibiotics, transfusions, insertion of IABP, and prior stroke.</jats:p>
収録刊行物
-
- BioMed Research International
-
BioMed Research International 2015 1-7, 2015
Hindawi Limited